Autologous Blood Injection for Treatment of Tennis Elbow

Background: Tennis elbow (TE) is a common myotendinosis. It was first described by Runge in ۱۸۷۳; different modes of treatment are used in management of TE. Objectives: This study aimed to report the results of autologous blood injection (ABI) in the treatment of TE. Materials and Methods: A prospective case study was performed to evaluate the results of ABI in the management of TE. The level of pain based on Nirschl phase scale (NPS) and a visual analogue scale (VAS) was calculated before and ۱, ۳ and ۶ months after injection; then satisfaction was assessed. Results: Twenty-nine patients with diagnosed TE were treated by ABI (۲۴% males, ۷۶ % female). The mean age of the patients was ۴۴.۱ ± ۵.۲ years. The level of pain on VAS decreased from ۶.۴۶ ± ۲.۰۸ to ۰.۵۴ ± ۰.۷ (P=۰.۰۰۱) and on NPS from ۶.۱۵ ± ۱.۴۸ to ۰.۵۴ ± ۰.۷۶ (P = ۰.۰۰۱) ۶ months after treatment. At the end of the study, ۸۴% of patients expressed a high level of satisfaction. Conclusions: Given the acceptable outcomes, autologous blood injection can be considered a good treatment option for TE when traditional treatment has fails.

کلیدواژه ها:

Tennis Elbow ، Blood injection ، Autologous